These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17287717)

  • 21. [Fungal infections in children with malignant disease].
    Michel G
    Arch Pediatr; 2011 May; 18 Suppl 1():S3-7. PubMed ID: 21596284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993.
    Chen YC; Chang SC; Sun CC; Yang LS; Hsieh WC; Luh KT
    Infect Control Hosp Epidemiol; 1997 May; 18(5):369-75. PubMed ID: 9154483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidemiology of invasive mycoses. Experience of a university hospital center in Paris].
    Hennequin C
    Rev Med Interne; 1996; 17(9):754-60. PubMed ID: 8959131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
    Salavert-Lletí M; Zaragoza-Crespo R
    Rev Iberoam Micol; 2009 Mar; 26(1):81-9. PubMed ID: 19463284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immune response to fungal infections.
    Shoham S; Levitz SM
    Br J Haematol; 2005 Jun; 129(5):569-82. PubMed ID: 15916679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylaxis of invasive mycoses in solid organ transplantation.
    Alexander BD
    Curr Opin Infect Dis; 2002 Dec; 15(6):583-9. PubMed ID: 12821834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Echinocandins: role in antifungal therapy, 2005.
    Zaas AK; Alexander BD
    Expert Opin Pharmacother; 2005 Aug; 6(10):1657-68. PubMed ID: 16086652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
    Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
    Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology.
    Ellis M; Richardson M; de Pauw B
    Hosp Med; 2000 Sep; 61(9):605-9. PubMed ID: 11048599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
    Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Invasive mycoses during hematopoietic stem cell transplantation].
    Popova MO; Zubarovskaia LS; Klimko NN; Vavilov VN; Volkova AG; Ziuzgin IS; Ignat'eva GM; Alianskiĭ AL; Paina OV; Babenko EV; Blagodarova-Smirnova MS; Smirnov BI; Afanas'ev BV
    Ter Arkh; 2012; 84(7):50-7. PubMed ID: 23038972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention.
    Suleyman G; Alangaden GJ
    Infect Dis Clin North Am; 2021 Dec; 35(4):1027-1053. PubMed ID: 34752219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview of systemic fungal infections.
    Rolston K
    Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):11-4. PubMed ID: 11757845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century.
    Walsh TJ; Groll AH
    Transpl Infect Dis; 1999 Dec; 1(4):247-61. PubMed ID: 11428996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of opportunistic fungal infections in India.
    Chakrabarti A; Chatterjee SS; Shivaprakash MR
    Nihon Ishinkin Gakkai Zasshi; 2008; 49(3):165-72. PubMed ID: 18689964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The challenge of invasive fungal infection.
    de Pauw BE; Meunier F
    Chemotherapy; 1999 Jun; 45 Suppl 1():1-14. PubMed ID: 10394016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical aspects of fungal infection in organ transplant recipients.
    Hibberd PL; Rubin RH
    Clin Infect Dis; 1994 Aug; 19 Suppl 1():S33-40. PubMed ID: 7948569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive Fungal Infections After Kidney Transplantation: A Single-center Experience.
    Santos T; Aguiar B; Santos L; Romaozinho C; Tome R; Macario F; Alves R; Campos M; Mota A
    Transplant Proc; 2015 May; 47(4):971-5. PubMed ID: 26036497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The emerging epidemiology of mould infections in developing countries.
    Chakrabarti A; Singh R
    Curr Opin Infect Dis; 2011 Dec; 24(6):521-6. PubMed ID: 21799406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.